BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The company recently merged with Streamex Exchange Corporation.
The offering is subject to market conditions, with the net proceeds intended for purchasing gold bullion, working capital, and general corporate purposes.
Proposed Offering
BioSig intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds will go towards purchasing gold bullion, working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers for the offering.
Registration Statement
The offering is made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC on December 17, 2024.
- The completion of the offering is subject to market conditions with uncertainties regarding timing, size, and terms.
- The offering is aimed at funding the purchase of gold bullion and supporting the company's financial operations.
BioSig Technologies Inc. aims to utilize the proceeds from the public offering strategically to enhance its financial position and further its investment policies. The collaboration with book-running managers reflects a strategic approach to the offering process.